On our way to Bialystok to start an interesting mito study ⁦Jens Frey Halling⁩ ⁦Lukasz Szczerbinski⁩

Starting up ⁦⁦experiments ⁦Lukasz Szczerbinski⁩ ⁦Oroboros Instruments⁩

Today at #AllofUsRC23, researchers talk about healthcare access microtrends. Excited to hear Dr. Lukasz Szczerbinski's take on how validated algorithms using polygenic risk scores can support diabetes #precisionmedicine. More info on the session below:

Thanks AllofUsResearch for the opportunity to present our study on new algorithms for identifying diabetes in the All of Us EHR data. Shoutout to our amazing team at MGH/Broad, including our supervisors Josep M Mercader 🎗 , Alisa Manning , and Miriam Udler #AllofUsRC2023

🎉 Thrilled to join Alicia & Josep M Mercader 🎗 in a study using #TOPMed to analyze rare genetic variations in the Latino population. Our work highlights TOPMed's power in uncovering new T2D links & improving polygenic scores. 🧬🔬 #T2D #Genetics #Diversity

Incredible tour de force by the amazing Alicia Chagoya shows the value of TOPMed imputation in Latino cohorts. Thanks to all co-authors, Philip Schroeder, Ravi Mandla, Joanne B. Cole Miriam Udler Lukasz Szczerbinski Vicky Kaur Alisa Manning Jose Florez Aaron Leong and many more!

Congratulations Jose Florez 🎉🎉 Proud to be part of your team and witness your exceptional leadership!! Exciting times ahead for the entire MassGeneral News community

Great time in Copenhagen with my team, meeting our collaborators at University of Copenhagen Research to discuss ongoing projects and present the first results of our oral semaglutide pharmacogenomics study (GAROS). Thanks Steen Larsen for having us!

1/6) Type 2 diabetes (T2D) is a heterogeneous disease for which causal pathways are incompletely understood. In our new preprint, we identify 12 genetic T2D subtypes and demonstrate how they may explain variation in polygenic risk across populations doi.org/10.1101/2023.0…

Ever wonder why people get type 2 diabetes at different BMI thresholds? So proud of this incredible effort to generate multi-ancestry T2D genetic clusters & inform on disease heterogeneity!

Thank you EASD for the opportunity to present our results and for the award for best abstract by young scientist! Kudos to my team at MassGeneral News, Broad Institute and UMB, especially Josephine Li, Josep M Mercader 🎗 and Jose Florez #EASD2023 #diabetes

⭐️ OUT NOW Communications Medicine - Misra et al. conduct a systematic review of the evidence on the precision subclassification of #T2D | Shivani Misra Miriam Udler Robert Wagner #PMDI nature.com/articles/s4385…

Thrilled to share our latest paper in The Lancet Diabetes & Endocrinology! Together with Jose Florez, we delve into the advances in obesity genetics, its metabolic consequences, and the future of precision obesity management. It's time to emphasize obesity-centered diabetes care! 🧬🎯💊 #obesity

Queen Iga Świątek 👑 #1GA

It's out! 🎉 The latest article from the Miriam Udler lab has been published today in #NatureMedicine. Honored to be a part of this incredible team and to work alongside such dedicated scientists under Miriam's leadership! #DiabetesResearch #Genetics Broad Institute CGM at MGH

The default clinical practice of 24-h continuous nutrition for critically ill patients should be reconsidered given its lack of evidence of safety and efficacy over more physiologic daytime feeds. Michele Wang Melissa Knauert Mass General Anesthesia Critical Care ccforum.biomedcentral.com/articles/10.11…

Had a great time attending the EASD meeting last week! So much excellent science and productive meetings with collaborators. A special shout-out to the fantastic precision medicine in diabetes session led by Shivani Misra , with amazing talks from Miriam Udler, Emily K. Sims and

What I love most about science is the collaboration and teamwork. Just came back from Düsseldorf, where we went with my team to meet Robert Wagner and his fantastic group at the DDZ. It was a great start to our collaboration, with exciting discussions about ongoing projects and future